Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nexium Oral vs IV in GERD
NCT00626262Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Jul 2002
- Primary completion
- Oct 2002
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of esomeprazole in gastroesophageal reflux disease (GERD), sponsored by AstraZeneca. Started Jul 2002; status: completed.
02
Drugs
esomeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT00626262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00626262.